Zenas BioPharma, Inc. Common Stock (NASDAQ: ZBIO) last traded at $25.16, down 4.70% on the session. The quote above updates while this page is open; the figures below are drawn from Zenas BioPharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Zenas BioPharma, Inc. Common Stock trades on NASDAQ under the ticker ZBIO. Its market capitalisation is $1.64 billion.
Valuation measures for Zenas BioPharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.64B |
|---|---|
| Enterprise value | $1.90B |
| Price / sales | 163.98 |
| Price / book | 6.64 |
| Beta | 0.75 |
Trailing-twelve-month figures tagged in Zenas BioPharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.00M |
|---|---|
| Net income (TTM) | -$484.38M |
| EPS (TTM) | -$9.62 |
| Operating margin | -4755.73% |
| Return on equity | -196.03% |
| Cash | $196.58M |
Range and volume for ZBIO over the past 52 weeks.
| 52-week high | $44.60 |
|---|---|
| 52-week low | $13.50 |
| Volume | 519.6K |
| Average volume | 721.1K |
| Previous close | $26.40 |
Invest a chosen dollar amount in Zenas BioPharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ZBIO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.